Skip to main content
. 2019 Mar 27;7(3):e12284. doi: 10.2196/12284

Table 1.

Characteristics of the study population (N=223).

Characteristics Healthy patients (n=79) AFa patients with sinus rhythm (n=42) AF patients with AF (n=102) Total population (N=223)
Age (years), mean (SD) 75 (8) 78 (8) 79 (8) 77 (8)
Male, n (%) 32 (41) 21 (50) 51 (49.0) 104 (46.6)
Resting heart rate, bpmb, mean (SD) 71 (14) 70 (18) 83 (20) 77 (19)
Systolic BPc, mm Hg, mean (SD) 130 (16) 129 (14) 129 (17) 129 (16)
Diastolic BP, mm Hg, mean (SD) 73 (8) 74 (7) 74(11) 74 (9)
Risk factors

CHA2 DS2-VAScd-score, median (IQRe) 3 (2-4) 4 (3-5) 5 (3-6) 4 (3-6)

Congestive heart failure, n (%) 12 (15) 10 (24) 42 (41.2) 64 (28.7)

Diabetes, n (%) 9 (11) 9 (21) 27 (26.5) 45 (20.2)

Stroke or transient ischemic attack, n (%) 9 (11) 9 (21) 32 (31.4) 50 (22.4)

Atherosclerotic disease, n (%) 19 (24) 22 (52) 48 (47.1) 89 (40.0)
Medication use




Anticoagulation, n (%) 2 (3) 30 (71) 92 (90.2) 124 (55.6)

ACEf inhibitor, n (%) 11 (14) 13 (31) 32 (31.4) 56 (25.1)

Angiotensin receptor blocker, n (%) 11 (14) 10 (24) 21 (20.6) 42 (18.8)

Beta blocker, n (%) 33 (42) 22 (52) 71 (69.6) 126 (56.5)

Diuretics, n (%) 16 (20) 11 (26) 53 (52.0) 80 (35.9)
Mobile phone handling




Mobile phone ownership, n (%) 19 (24) 6 (14) 11 (10.8) 36 (16.1)

Mobile phone handling, median (IQR) 3 (2-4) 4 (2-4) 4 (3-4) 4 (2-4)

aAF: atrial fibrillation.

bbpm: beats per minute.

cBP: blood pressure.

dCHA2 DS2-VASc: congestive heart failure, hypertension, age, diabetes mellitus, previous stroke, vascular disease, and sex category.

eIQR: interquartile range.

fACE: angiotensin‑converting enzyme.